Sigyn Therapeutics files PCT patent for ImmunePrep platform to enhance antibody delivery for cancer treatment

Sigyn Therapeutics, Inc.

Filed PCT application US24/28579 on May 9, 2024 for 'DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES'.
Patent covers ImmunePrep platform aimed at improving delivery of immunotherapeutic antibodies for cancer.
Inventors listed: Chairman and CEO James A. Joyce and Annette M. Marleau.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.